MephamT.B., CombesR.D., BallsM., BarbieriO., BlokhuisH.J., CostaP., CrillyR.E., de Cock BuningT., DelpireV.C., O'HareM.J., HoudebineL-M., van KreijlC.F., van der MeerM., ReinhardtC.A., WolfE., & van ZellerA-M. (1998). The use of transgenic animals in the European Union. The report and recommendations of ECVAM workshop 28. ATLA26, 21–43.
2.
MephamT.B., & CrillyR.E. (1999). Bioethical issues in the generation and use of transgenic farm animals. ATLA27, Suppl. 1, 847–855.
3.
van der MeerM., CostaP., BaumansV., OlivierB., & van ZutphenB. (1999). Welfare assessment of transgenic animals: behavioural responses and morphological development of newborn mice. ATLA27, Suppl. 1, 857–868.
4.
DelpireV.C., MephamT.B., & BallsM. (1999). A proposal for a new ethical scheme addressing the use of laboratory animals for biomedical purposes. ATLA27, Suppl. 1, 869–881.
5.
ApplebyM.C. (1999). Tower of Babel: variation in ethical approaches, concepts of welfare and attitudes to genetic manipulation. Animal Welfare8, 381–390.
6.
VarnerG. (1999). Should you clone your dog? An animal rights perspective on somacloning. Animal Welfare8, 407–420.
7.
JenkinsE.S., & CombesR.D. (1999). The welfare problems associated with using transgenic mice to bioassay for bovine spongiform encephalopathy. Animal Welfare8, 421–431.
8.
MertensC., & RülickeT. (1999). Score sheets for the monitoring of transgenic mice. Animal Welfare8, 433–438.
9.
JenkinsE.S., & FrancisR.F. (1999). New guidance notes for projects generating or maintaining genetically modified animals. ATLA27, Suppl. 1, 883–902.
10.
Anon. (1999). ECVAM workshop 28: a research perspective. ATLA27, Suppl. 1, 815–818.
11.
DeanS. (1999). ECVAM workshop 28: an industry perspective. ATLA27, Suppl. 1, 819–821.
12.
GriffinG., & GauthierC. (1999). Do Canadian Council on Animal Care guidelines meet ECVAM recommendations on transgenic animals?ATLA27, 823–825.
13.
van ZellerA-M., & CombesR.D. (1999). Transgenic mouse bioassays for carcinogenicity testing: a step in the right direction?ATLA27, Suppl. 1, 839–846.